PCI in T2DM: more frequent In-stent Restenosis in Patients with poor glycemic Control?

被引：0
|
作者：
Dahm, Johannes B.
机构：
来源：
AKTUELLE KARDIOLOGIE | 2024年 / 13卷 / 05期
关键词：
D O I：
10.1055/a-2388-9298
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The influence of glycemia control on the risk of stent failure in patients with type 2 diabetes (T2 D) is currently unknown. Hyperglycemia is a key factor in the development of restenosis due to hyperglycemia-induced endothelial dysfunction and excessive production of reactive oxygen species. The aim of this study was to investigate whether poor glycemia control is associated with a higher risk of stent failure in patients with T2 D.
引用
收藏
页码：350 / 350
页数：1
相关论文
共 50 条
  • [31] Development of a Personalized, Patient-Centered Glycemic Control Benchmarking Tool for T2DM
    Testa, Marcia A.
    Simonson, Donald C.
    DIABETES, 2014, 63 : A303 - A303
  • [32] Glycated Albumin for Glycemic Control in T2DM Population: A Multi-Dimensional Evaluation
    Ferrario, Lucrezia
    Schettini, Fabrizio
    Avogaro, Angelo
    Bellia, Chiara
    Bertuzzi, Federico
    Bonetti, Graziella
    Ceriello, Antonio
    Ciaccio, Marcello
    Romanelli, Massimiliano Corsi
    Dozio, Elena
    Falqui, Luca
    Girelli, Angela
    Nicolucci, Antonio
    Perseghin, Gianluca
    Plebani, Mario
    Valentini, Umberto
    Zaninotto, Martina
    Castaldi, Silvana
    Foglia, Emanuela
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2021, 13 : 453 - 464
  • [33] Glycemic Control Rate of T2DM Outpatients in China: A Multi-Center Survey
    Chen, Rong
    Ji, Linong
    Chen, Liming
    Chen, Li
    Cai, Dehong
    Feng, Bo
    Kuang, Hongyu
    Li, Hong
    Li, Yiming
    Liu, Jing
    Shan, Zhongyan
    Sun, Zilin
    Tian, Haoming
    Xu, Zhangrong
    Xu, Yancheng
    Yang, Yuzhi
    Yang, Liyong
    Yu, Xuefeng
    Zhu, Dalong
    Zou, Dajin
    MEDICAL SCIENCE MONITOR, 2015, 21 : 1440 - 1446
  • [34] Empagliflozin as Add-On to Metformin for 24 Weeks Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
    Haering, Hans-Ulrich
    Merker, Ludwig
    Seewaldt-Becker, Elke
    Weimer, Marc
    Meinicke, Thomas
    Broedl, Uli C.
    Woerle, Hans J.
    DIABETES, 2013, 62 : A282 - A282
  • [35] Improvements in Glycemic Control are Associated With a Decline in the Severity of Depressive Symptoms in Patients With Type 2 Diabetes Mellitus (T2DM)
    Dzida, Grzegorz J.
    Karnieli, Eddy
    Svendsen, Anne Louise
    Hermanns, Norbert
    DIABETES, 2013, 62 : A212 - A212
  • [36] Empagliflozin as Add-On to Pioglitazone With or Without Metformin Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
    Kovacs, Christopher
    Seshiah, Veeraswamy
    Swallow, Ros
    Jones, Russell
    Rattunde, Henning
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES, 2013, 62 : A291 - A291
  • [37] Pioglitazone (PIO) improves glycemic control in drug-therapy naive patients with type 2 diabetes (T2DM)
    Herz, M
    Tan, M
    Johns, D
    Robertson, KE
    Gonzalez, B
    Reviriego, J
    Grossman, L
    DIABETES, 2002, 51 : A481 - A481
  • [38] Factors associated with glycemic control in patients with T2DM: evidence from a cross-sectional study in China
    Luo, Wenting
    Zhang, Jiayu
    Luo, Yanxing
    Wu, Qiuwan
    Chen, Longfei
    Liu, Changqin
    Lin, Minqiang
    BMC ENDOCRINE DISORDERS, 2024, 24 (01)
  • [39] Lixisenatide Significantly Improves Glycemic Control in Asian Patients with T2DM Insufficiently Controlled on Basal Insulin±SU
    Seino, Yutaka
    Min, Kyungwan
    Niemoeller, Elisabeth
    Takami, Akane
    DIABETES, 2011, 60 : A76 - A76
  • [40] Frequent Hypoglycemia Among Elderly Patients With Poor Glycemic Control
    Munshi, Medha N.
    Segal, Alissa R.
    Suhl, Emmy
    Staum, Elizabeth
    Desrochers, Laura
    Sternthal, Adrianne
    Giusti, Judy
    McCartney, Richard
    Lee, Yishan
    Bonsignore, Patricia
    Weinger, Katie
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (04) : 362 - 364
12345